Bispecific CAR-T cells targeting FAP and GPC3 have the potential to treat hepatocellular carcinoma.
Zhou L, Li Y, Zheng D, Zheng Y, Cui Y, Qin L, Tang Z, Peng D, Wu Q, Long Y, Yao Y, Wong N, Lau J, Li P.
Zhou L, et al. Among authors: cui y.
Mol Ther Oncol. 2024 May 23;32(2):200817. doi: 10.1016/j.omton.2024.200817. eCollection 2024 Jun 20.
Mol Ther Oncol. 2024.
PMID: 38882528
Free PMC article.